Enzolytics Inc. CEO: Popularity of Immune Boosters Have Increased with Consumers

Industry: Health & Fitness

IPF Immune™ Now Available on OneLavi.com

Boca Raton, FL (PRUnderground) January 12th, 2023

Consumers have fallen in love with immune health supplements.

“Sales skyrocketed during the past few years,” said Charles S. Cotropia, CEO of Enzolytics, Inc., a Texas biotech company. “Everyone wants to protect themselves. Health is their No. 1 priority. Immune booster supplements look like they will see still strong numbers in the future.

“We are still more focused than ever before on our health,” Mr. Cotropia said. “The ‘Vitamin, Mineral, Supplement’ category is still at historic highs. For the first time, 80 percent of American adults are taking dietary supplements.”

To give consumers another immune booster option, Enzolytics has developed an over-the-counter immune health dietary supplement:  IPF Immune™.

“Our product supports your immune system,” said Harry H. Zhabilov, Enzolytics’ Chief Scientific Officer.

Enzolytics IPF Immune™, which is gluten-free, is a nutritional supplement that is taken orally two consecutive days per week for eight consecutive weeks.

Mr. Cotropia said Enzolytics is reaching out to retail outlets to carry Immune IPF™.

“Our team has met with buyers from some of the most sought-after retailers in the country,” he added. “Now, we are following up with them.”

To purchase Immune IPF, please visit OneLavi.com.

Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. This press release is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please check with your doctor. The news site hosting this press release is not associated with Enzolytics, Inc. It is merely publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product or service.

Company Contact:
Enzolytics, Inc.
2000 North Central Expressway
Plano, TX 75074

Research Center
Enzolytics, Inc.
Texas A&M University
Institute for Preclinical Studies
College Station, TX 77843-44
SOURCE: Enzolytics, Inc.

About Enzolytics, Inc.

Enzolytics Inc. is a Texas-based biotechnology company that focuses on therapeutics to treat numerous human health medical conditions. In addition to Enzolytics IPF Immune™, which will be on the U.S. market soon, the Company is developing other therapeutics for treating multiple infectious diseases.

Print Friendly, PDF & Email

Become a Fan

Press Contact

Robert Grant
Contact Us

Image Gallery